Pharmacy is undergoing the most significant economic restructuring in its modern history, says Lari Harding, senior vice president of health care industry affairs and strategic partnerships at Inmar Intelligence. A sector historically sustained by drug cost–based margins is being reshaped by federal policy into a model where financial viability depends on transparent reimbursement, predictable cash flow and direct payment for pharmacist-delivered clinical services. This transformation is not the result of a single reform but of multiple federal initiatives whose combined effects are redefining how pharmacies are paid, how cash flows through the system, and how professional care is valued.
At the same time, consumers are more focused than ever on health and wellness and affordable care. Changing consumer behaviors, combined with federal reforms, are pushing the ecosystem to strategically navigate this shift in a way that protects patient safety, access and affordability.
Having spent decades in the industry and seen this evolution firsthand, Harding finds this moment especially meaningful — because it requires deep, coordinated engagement across stakeholders to translate complexity into practical solutions.
At Inmar, Harding works with the nation’s leading health care value chain stakeholders to improve patient safety, access and affordability. A patent-holding innovator, frequently published author and business leader, she has served in a variety of leadership roles across business functions in her more than 30 years at Inmar and possesses particular insight into solution commercialization, life sciences, pharmacy operations and patient engagement.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
